GlassScriptPhysician profile
Andrea B Dudley
NPI 1568544773
$2,737.05
in general payments reported to CMS, 2019-2025
14 companies · $405 in 2025
The $405 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $293 · 2020: $215 · 2021: $256 · 2022: $523 · 2023: $623 · 2024: $422 · 2025: $405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,449.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $854.36 | 2022-2025 | Miebo, Infuse, Xiidra |
| Alcon Vision LLC | $367.59 | 2020-2025 | Tryptyr, Precision 7, Total30 |
| Allergan, INC. | $255.22 | 2020-2022 | |
| Tarsus Pharmaceuticals, INC. | $243.08 | 2024-2025 | Xdemvy |
| The Cameron-Ehlen Group, INC. | $241.14 | 2020-2021 | |
| Shire North American Group INC | $170.54 | 2019 | |
| Rxsight INC | $124.28 | 2023 | Rxsight Injector Cartridge, Rxsight Injector Handpiece, Rxsight Contact Lens |
| Sun Pharmaceutical Industries INC. | $115.25 | 2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $102.59 | 2019-2021 | |
| Oyster Point Pharma, INC. | $66.27 | 2022-2023 | Tyrvaya |
| New World Medical,INC. | $60.64 | 2023 | |
| Abbvie INC. | $51.12 | 2022-2023 | Vuity, Lumigan |
| Novartis Pharmaceuticals Corporation | $50.14 | 2020-2023 | |
| Abb Con-Cise Optical Group LLC | $34.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Dudley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.